VMG Healthcare Products S.A Pharmaceutical Import Profile — Costa Rica (DGFT 2022–2026)

Name: VMG Healthcare Products S.A Pharmaceutical Import Records from India — 2 Products, $94.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

VMG Healthcare Products S.A — Pharmaceutical Importer Profile (2026) | 2 Products, $94.8K Trade | TransData Nexus

VMG Healthcare Products S.A

Pharmaceutical Importer · Costa Rica · Analgesics & Antipyretics Focus · $94.8K Total Trade · DGFT Verified

VMG Healthcare Products S.A is a pharmaceutical importer based in Costa Rica with a total trade value of $94.8K across 2 products in 1 therapeutic categories. Based on 4 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. VMG Healthcare Products S.A sources from 18 verified Indian suppliers, with Lifecare Innovations Private Limited accounting for 20.0% of imports.

VMG Healthcare Products S.A — Import Portfolio & Supplier Network

VMG Healthcare Products S.A import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to VMG Healthcare Products S.A?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Lifecare Innovations Private Limited	$319.5K	7	20.0%
Gland Pharma Limited	$312.5K	10	19.5%
Vmg Pharmaceuticals Private Limited	$305.6K	24	19.1%

What Formulations Does VMG Healthcare Products S.A Import?

Formulation	Value	Ships
Vancomycin hydrochloride for injection	$155.4K	5
Pharmaceuticals article / ods / product / item - gabapentin capsules USP 300MG gabapentina 300 MG Pack of 03x10s	$100.0K	2
Caspofungina 50MG(caspofungin acetate for injection 50MG/vial)	$100.0K	2
Vancomycin hydrochloride for injection USP 500MG/vial 10ML	$57.1K	2
Valganciclovir 450 MG tablets (Each	$50.0K	1
Penicillamine USP 250 MG capsules	$50.0K	1
Harmless medicines indomethacin suppositories 100MG 20x5s	$50.0K	1
Pharmaceuticals products gabapentin capsules USP 300MG gabapentina 300 MG Pack of 03x10s	$50.0K	1
Liposomal amphotericin b for infusion	$50.0K	1
Claritrimicina 250MG/5ML Each 5ML afterreconstitution contains clarithromycinusp 250MG b jud23-003,4 m 06/23 e	$50.0K	1
Liposomal amphotericin b for infusion fungisome 50MG/50ML b/n:50f23-03950f23-040 md:05/23	$50.0K	1
Harmless medicines : indomethacin suppositories 100MG (14,000 packs) (20x5's)( batch no. qx2329 to batch no. qx2342 )	$50.0K	1
Anfotericina b liposomal 50MG/50ML batchno-50f23-057 mfg dt-dec-23 exp	$50.0K	1
Anfotericina b liposomal 50MG 50ML liposomal amphotericin b 50MG 50ML b n 50f25 007 md mar 25 ed feb	$50.0K	1
Pharmaceuticals INJ norepinephrine bitartrate USP 1MG ML 4MG 4ML amp bn e902501 e902502 md apr 25 ed mar	$50.0K	1

VMG Healthcare Products S.A imports 76 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Indomethacin	Analgesics & Antipyretics	$61.4K	2	0.7%	11
2	Fentanyl	Analgesics & Antipyretics	$33.4K	2	0.9%	10

VMG Healthcare Products S.A imports 2 pharmaceutical products across 1 categories into Costa Rica totaling $94.8K.

VMG Healthcare Products S.A — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

VMG Healthcare Products S.A. is a prominent pharmaceutical importer and distributor based in San José, Costa Rica. Established in 1998, the company has grown to become one of the largest distribution entities in the country, holding a public market share of 14% and achieving an annual turnover exceeding $20 million USD. VMG specializes in providing a comprehensive range of medical and pharmaceutical products, including surgical instruments, medical dressings, and a variety of pharmaceutical formulations. Their clientele encompasses both private and governmental hospitals, institutions, laboratories, doctors, and nurses, reflecting their significant role in Costa Rica's healthcare supply chain.

The company's headquarters are located at Autopista Prospero Fernandez, 800 meters northwest of the Paso a Desnivel, in Escazú, San José, Costa Rica. This strategic location facilitates efficient distribution and logistics operations across the region. VMG Healthcare Products S.A. operates as an independent entity and is not listed as a subsidiary of any parent company. Their extensive product portfolio and established market presence underscore their pivotal role in the pharmaceutical distribution sector within Costa Rica.

2Distribution Network

VMG Healthcare Products S.A. maintains a robust distribution network throughout Costa Rica, with its central operations based in Escazú, San José. While specific details about additional warehouse locations are not publicly disclosed, the company's strategic positioning in Escazú suggests a centralized distribution model aimed at optimizing logistics and supply chain efficiency. This centralization likely enables the company to effectively serve both urban and rural healthcare facilities across the country. The company's established market presence and efficient logistics capabilities underscore its commitment to delivering high-quality medical and pharmaceutical products to a diverse clientele.

3Industry Role

VMG Healthcare Products S.A. serves as a primary wholesaler and distributor within Costa Rica's pharmaceutical supply chain. By importing a diverse array of pharmaceutical formulations and medical devices, the company plays a crucial role in ensuring the availability of essential healthcare products to hospitals, clinics, laboratories, and healthcare professionals across the nation. Their extensive product range and established market presence underscore their significant position in the Costa Rican healthcare sector.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — VMG Healthcare Products S.A

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

VMG Healthcare Products S.A. demonstrates a high degree of sourcing concentration, with a portfolio comprising only two imported products—Indomethacin and Fentanyl—across a single therapeutic category, Analgesics & Antipyretics. This narrow focus indicates a strategic choice to specialize in specific high-demand products within the analgesic segment. The company's total import value from India amounts to $95,000 USD, distributed over four shipments. The top five products imported from India include Indomethacin ($61,000 USD) and Fentanyl ($33,000 USD), accounting for 100% of the company's pharmaceutical imports from India. This concentration suggests a deliberate strategy to maintain a streamlined and focused product offering, potentially enhancing operational efficiency and market expertise in these specific products.

The shipment data reveals a stable relationship with Indian suppliers, with the top five suppliers—Lifecare Innovations Private Limited, Gland Pharma Limited, VMG Pharmaceuticals Private Limited, Panacea Biotec Pharma Limited, and Meridian Enterprises Private Limited—accounting for a significant portion of the total import value. This consistent sourcing pattern indicates a strong and reliable supply chain, reducing the risks associated with supplier variability and ensuring consistent product quality. However, the lack of diversification in product categories and suppliers may expose the company to risks related to supply chain disruptions or changes in supplier dynamics. To mitigate such risks, exploring additional product categories and diversifying supplier relationships could enhance supply chain resilience and operational flexibility.

Supply Chain Resilience

Importing Pharmaceuticals into Costa Rica — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Costa Rica

1Regulatory Authority & Framework

In Costa Rica, the Ministry of Health (Ministerio de Salud) is the primary regulatory authority overseeing the importation, registration, and distribution of pharmaceutical products. Pharmaceuticals, drugs, cosmetics, medical devices, and certain chemical products must obtain import permits valid for five years and be registered with the Ministry of Health before entering the Costa Rican market. This regulatory framework ensures that imported pharmaceutical products meet the country's health and safety standards, safeguarding public health.

The Costa Rican Institute of Social Security (Caja Costarricense de Seguro Social, CCSS) also plays a significant role in the procurement and distribution of medical supplies and pharmaceuticals. The CCSS requires bar code identification on all purchases of medicines and medical supplies upon entry into the Costa Rican market. This requirement is included in the specifications of all public and private tenders issued by the CCSS for medicines and medical supplies, facilitating efficient tracking and management of medical products within the healthcare system.

2Import Licensing & GMP

Import licenses are mandatory for pharmaceuticals, drugs, cosmetics, medical devices, and certain chemical products in Costa Rica. These licenses are issued by the Ministry of Health and are valid for five years. Additionally, imported pharmaceutical products must be registered with the Ministry of Health to ensure compliance with national health and safety standards. The Costa Rican Institute of Social Security (CCSS) requires bar code identification on all purchases of medicines and medical supplies upon entry into the Costa Rican market. This requirement is included in the specifications of all public and private tenders issued by the CCSS for medicines and medical supplies, facilitating efficient tracking and management of medical products within the healthcare system.

VMG Healthcare Products S.A — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

VMG Healthcare Products S.A.'s focus on importing Indomethacin and Fentanyl within the Analgesics & Antipyretics category indicates a strategic emphasis on high-demand pain management medications. The substantial import values—$61,000 USD for Indomethacin and $33,000 USD for Fentanyl—suggest a significant market demand for these products in Costa Rica.

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — VMG Healthcare Products S.A

What products does VMG Healthcare Products S.A import from India?

VMG Healthcare Products S.A imports 2 pharmaceutical products across 1 categories. Top imports: Indomethacin ($61.4K), Fentanyl ($33.4K).

Who supplies pharmaceuticals to VMG Healthcare Products S.A from India?

VMG Healthcare Products S.A sources from 18 verified Indian suppliers. The primary supplier is Lifecare Innovations Private Limited (20.0% of imports, $319.5K).

What is VMG Healthcare Products S.A's total pharmaceutical import value?

VMG Healthcare Products S.A's total pharmaceutical import value from India is $94.8K, based on 4 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does VMG Healthcare Products S.A focus on?

VMG Healthcare Products S.A imports across 1 categories. The largest: Analgesics & Antipyretics (100.0%).

Get Full VMG Healthcare Products S.A Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.